The pharmacology of the novel and selective sigma ligand, PD 144418 von AKUNNE, H. C, WHETZEL, S. Z, WILEY, J. N, CORBIN, A. E, NINTEMAN, F. W, TECLE, H, PEI, Y, PUGSLEY, T. A, HEFFNER, T. G

Volltext

Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant von Akunne, H.C, Zoski, K.T, Whetzel, S.Z, Cordon, J.J, Brandon, R.M, Roman, F, Pugsley, T.A

Volltext

Reduced amide bond neurotensin 8–13 mimetics with potent in vivo activity von Wustrow, D.J., Davis, M.D., Akunne, H.C., Corbin, A.E., Wiley, J.N., Wise, L.D., Heffner, T.G.

Volltext

PD 158771, a potential antipsychotic agent with D 2/D 3 partial agonist and 5-HT 1A agonist actions. I. Neurochemical effects von Akunne, H.C, Zoski, K.T, Davis, M.D, Cooke, L.W, Meltzer, L.T, Whetzel, S.Z, Shih, Y.H, Wustrow, D.J, Wise, L.D, MacKenzie, R.G, Georgic, L.M, Heffner, T.G, Pugsley, T.A

Volltext

PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects von AKUNNE, H. C, ZOSKI, K. T, GEORGIC, L. M, HEFFNER, T. G, PUGSLEY, T. A, DAVIS, M. D, COOKE, L. W, MELTZER, L. T, WHETZEL, S. Z, SHIH, Y. H, WUSTROW, D. J, WISE, L. D, MACKENZIE, R. G

Volltext

Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists von Pugsley, T.A., Akunne, H.C., Whetzel, S.Z., Demattos, S., Corbin, A.E., Wiley, J.N., Wustrow, D.J., Wise, L.D., Heffner, T.G.

Volltext

Novel small molecule neurotensin antagonists: 3-(1,5-diaryl-1,5-dioxopentan-3-yl)benzoic acids von Johnson, S.J., Akunne, H.C., Heffner, T.G., Kesten, S.R., Pugsley, T.A., Wise, L.D., Wustrow, D.J.

Volltext

The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat von Akunne, H C, Soliman, K F

Volltext

Functional activity of new C-terminal cyclic-neurotensin fragment analogs von Akunne, H.C, Darling, S, Zoski, K, Sefler, A.M, He, J.X, Sawyer, T.K, Pugsley, T.A, Cody, W.L

Volltext